Specify a stock or a cryptocurrency in the search bar to get a summary
Bio-Works Technologies AB
BIOWKSBio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden. Address: Virdings allé 18, Uppsala, Sweden, 754 50
Analytics
WallStreet Target Price
274.51 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BIOWKS
Dividend Analytics BIOWKS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIOWKS
Stock Valuation BIOWKS
Financials BIOWKS
Results | 2019 | Dynamics |